Summary
HCA Healthcare, Inc. (HCA) filed an 8-K on April 28, 2026, detailing the results of its Annual Meeting of Stockholders held on April 23, 2026. The meeting saw strong participation, with over 209 million shares represented. A key outcome was the overwhelming election of all nine director nominees to the Board of Directors, indicating robust shareholder confidence in the current leadership and governance structure. Furthermore, the Company's appointment of Ernst & Young LLP as its independent registered public accounting firm for 2026 received broad ratification, underscoring shareholder trust in the auditing process. Shareholder approval was also given to the advisory resolution on executive compensation, suggesting alignment between management's pay practices and investor sentiment. However, two shareholder proposals, one concerning healthcare consequences reporting and another on shareholders' right to act by written consent, failed to gain majority support.
Key Highlights
- 1All nine director nominees were overwhelmingly elected to the Board of Directors, reflecting strong shareholder support for HCA's leadership.
- 2The appointment of Ernst & Young LLP as the independent registered public accounting firm for 2026 was ratified by a significant majority of votes.
- 3Shareholders approved the non-binding advisory resolution on the company's executive compensation, indicating satisfaction with compensation practices.
- 4A significant majority of votes were cast against the shareholder proposal requesting a report on healthcare consequences.
- 5The shareholder proposal advocating for shareholders' right to act by written consent was also not approved by a substantial margin.
- 6A total of 209,777,472 shares, representing approximately 93.76% of outstanding shares, were represented at the Annual Meeting.
- 7Broker non-votes were recorded for director elections and executive compensation, but not for the ratification of the independent auditor.